Cai H, Chen Z, Hu W, Tan W, Wu H, Wang C
Department of Medicine, Hubei Enshi College, Enshi 445000, China.
Department of Gastroenterology, Chongqing People's Hospital, Chongqing 400000, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Nov 20;44(11):2201-2208. doi: 10.12122/j.issn.1673-4254.2024.11.17.
To investigate the protective effect of total flavonoids of extract against acetaminophen (APAP) -induced acute liver injury (ALI) and its molecular mechanism.
The main chemical constituents of total flavonoids of were obtained through literature search, and their pharmacological mechanisms were predicted using bioinformatics analysis. In a mouse model of APAP-induced ALI, the protective effects of 100, 200 and 400 mg/kg total flavonoids of and 150 mg/kg bifidus were evaluated by observing changes in blood biochemistry and liver histopathology and detecting expressions of the key proteins in the Nrf2/HO-1 signaling pathway.
Network pharmacology analysis suggested that the main active components in total flavonoids of for regulating APAPinduced liver injury included quercetin, lignocerol, caruric acid, and kaempferol, for which GO function enrichment analysis yielded 632 GO entries, including 472 involving biological processes, 42 involving cellular composition, and 118 involving molecular function. KEGG enrichment analysis showed that the total flavonoids of regulated APAP-induced liver injury mainly through ferroptosis-related signaling pathway. In mice with APAP-induced ALI, treatment with the total flavonoids significantly lowered ALT and AST levels, improved liver histopathology and inflammatory cell infiltration, reduced iron deposition in liver tissues, improved lipid peroxidation-related indexes, promoted the expressions of Nrf2, HO-1, SLC7A11, and GPX-4 proteins, and inhibited the expression of keap1 protein.
The total flavonoids of alleviate APAP-induced ALI in mice possibly by suppressing hepatocyte ferroptosis via activating the Nrf2/SLC7A11/GPX-4 signaling pathway.
探讨提取物总黄酮对乙酰氨基酚(APAP)诱导的急性肝损伤(ALI)的保护作用及其分子机制。
通过文献检索获取提取物总黄酮的主要化学成分,并利用生物信息学分析预测其药理机制。在APAP诱导的ALI小鼠模型中,通过观察血液生化指标和肝脏组织病理学变化以及检测Nrf2/HO-1信号通路关键蛋白的表达,评估100、200和400mg/kg提取物总黄酮及150mg/kg双歧杆菌的保护作用。
网络药理学分析表明,提取物总黄酮中调节APAP诱导肝损伤的主要活性成分包括槲皮素、木蜡醇、卡鲁酸和山奈酚,对其进行基因本体(GO)功能富集分析得到632个GO条目,其中涉及生物过程的有472个,涉及细胞组成的有42个,涉及分子功能的有118个。京都基因与基因组百科全书(KEGG)富集分析表明,提取物总黄酮主要通过铁死亡相关信号通路调节APAP诱导的肝损伤。在APAP诱导的ALI小鼠中,总黄酮治疗显著降低了谷丙转氨酶(ALT)和谷草转氨酶(AST)水平,改善了肝脏组织病理学和炎症细胞浸润,减少了肝脏组织中的铁沉积,改善了脂质过氧化相关指标,促进了Nrf2、HO-1、溶质载体家族7成员11(SLC7A11)和谷胱甘肽过氧化物酶4(GPX-4)蛋白的表达,并抑制了 Kelch样环氧氯丙烷相关蛋白1(keap1)蛋白的表达。
提取物总黄酮可能通过激活Nrf2/SLC7A11/GPX-4信号通路抑制肝细胞铁死亡,从而减轻APAP诱导的小鼠ALI。